鼻炎方联合布地奈德鼻喷雾剂治疗小儿肺经伏热型过敏性鼻炎临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R765.21;R276.1

基金项目:


Clinical Study on Rhinitis Prescription Combined with Budesonide Nasal Spray for Allergic Rhinitis in Children of Latent Heat in Lung Meridian Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察鼻炎方联合布地奈德鼻喷雾剂治疗小儿肺经伏热型过敏性鼻炎的临床疗效。方法:按 随机数字表法将92例肺经伏热型过敏性鼻炎患儿分为参照组及联合组各46例。参照组给予布地奈德鼻喷雾剂 治疗,联合组给予鼻炎方联合布地奈德鼻喷雾剂治疗。2组均治疗8周。比较2组中医症状评分、免疫功能指 标水平、炎症因子水平、临床疗效及不良反应发生率。结果:治疗后,2组喷嚏、鼻塞、流涕、鼻痒、鼻黏膜 肿胀、咽干、咽痒、咽红评分均较治疗前降低(P<0.05),联合组上述8项中医症状评分均低于参照组(P< 0.05)。治疗后,2组CD4+水平及CD4+/CD8+值均较治疗前升高(P<0.05),联合组CD4+水平及CD4+/CD8+值均 高于参照组(P<0.05);2组CD8+水平均较治疗前降低(P<0.05),联合组CD8+水平低于参照组(P<0.05)。 治疗后,2组血清C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6) 水平均较治疗前降 低(P<0.05),联合组血清CRP、TNF-α、IL-6水平均低于参照组(P<0.05)。联合组总有效率95.65%,高于 参照组80.43%(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:鼻炎方联合布地 奈德鼻喷雾剂治疗小儿肺经伏热型过敏性鼻炎疗效理想,不但能改善患儿的临床症状和免疫功能,还可降低炎 症因子水平。

    Abstract:

    Abstract:Objective:To observe the clinical effect of Rhinitis Prescription combined with Budesonide Nasal Spray on allergic rhinitis in children of latent heat in the lung meridian type. Methods : A total of 92 cases of children with allergic rhinitis of latent heat in the lung meridian type were divided into the reference group and the combination group according to the random number table method,with 46 cases in each group. The reference group was treated with Budesonide Nasal Spray,and the combination group was treated with Rhinitis Prescription combined with Budesonide Nasal Spray. Both group were treated for eight weeks. Traditional Chinese medicine(TCM) symptom scores, immune function indexes levels, the levels of inflammatory factors levels, clinical effects, and the incidence of adverse reactions were compared between the two groups. Results:After treatment,the scores of sneezing,nasal congestion, running nose,nasal itching,swelling nasal mucosa,dry throat,itching throat,and redness of throat in the two groups were decreased when compared with those before treatment (P<0.05), and the above eight scores in the combination group were lower than those in the reference group (P<0.05). After treatment,CD4+ levels and CD4+/CD8+ values in the two groups were increased when compared with those before treatment (P<0.05), and CD4+ levels and CD4+/CD8+ values in the combination group were higher than those in the reference group (P<0.05); CD8+ levels in the two groups were decreased when compared with those before treatment (P<0.05),and CD8+ levels in the combination group was lower than that in the reference group (P<0.05). After treatment, the levels of C-reactive protein (CRP), tumor necrosis factor (TNF- α), and interleukin-6 (IL-6) in serum in the two groups were decreased when compared with those before treatment (P<0.05),and the levels of CRP,TNF-α,and IL-6 in serum in the combination group were lower than those in the reference group (P<0.05). The total effective rate was 95.65% in the combination group,higher than that of 80.43% in the reference group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Rhinitis Prescription combined with Budesonide Nasal Spray has satisfying curative effect on the treatment of allergic rhinitis in children of latent heat in the lung meridian type. They can not only improve clinical effects and immune function of patients but also reduce inflammatory factors.

    参考文献
    相似文献
    引证文献
引用本文

苏洁,吴婷,况琦.鼻炎方联合布地奈德鼻喷雾剂治疗小儿肺经伏热型过敏性鼻炎临床研究[J].新中医,2024,56(17):79-82

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-09-11
  • 出版日期: